Balaji Jothishankar, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sezary Syndrome | 2 | 2019 | 80 | 1.230 |
Why?
|
| Mycosis Fungoides | 2 | 2019 | 169 | 1.150 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 3 | 2021 | 210 | 0.860 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 2020 | 36 | 0.690 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2020 | 180 | 0.620 |
Why?
|
| Depsipeptides | 1 | 2019 | 95 | 0.620 |
Why?
|
| Electrons | 1 | 2019 | 264 | 0.580 |
Why?
|
| Alopecia | 5 | 2024 | 416 | 0.570 |
Why?
|
| Skin Pigmentation | 1 | 2019 | 278 | 0.560 |
Why?
|
| Skin Neoplasms | 4 | 2020 | 5860 | 0.550 |
Why?
|
| Radiotherapy | 1 | 2019 | 1497 | 0.390 |
Why?
|
| Skin Diseases | 1 | 2019 | 1084 | 0.360 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 2571 | 0.350 |
Why?
|
| Hydroxychloroquine | 2 | 2023 | 427 | 0.310 |
Why?
|
| Skin | 2 | 2020 | 4499 | 0.270 |
Why?
|
| Lichen Planus | 1 | 2023 | 70 | 0.200 |
Why?
|
| Dermatology | 2 | 2023 | 905 | 0.180 |
Why?
|
| Alopecia Areata | 1 | 2023 | 130 | 0.180 |
Why?
|
| Spironolactone | 1 | 2024 | 415 | 0.170 |
Why?
|
| Hair Color | 1 | 2019 | 131 | 0.160 |
Why?
|
| International Normalized Ratio | 1 | 2020 | 382 | 0.150 |
Why?
|
| Reproduction | 2 | 2013 | 645 | 0.150 |
Why?
|
| Doxycycline | 1 | 2020 | 348 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 354 | 0.150 |
Why?
|
| Platelet Count | 1 | 2020 | 784 | 0.140 |
Why?
|
| Melanins | 1 | 2019 | 291 | 0.140 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 350 | 0.140 |
Why?
|
| Melanocytes | 1 | 2019 | 509 | 0.130 |
Why?
|
| Culture | 1 | 2019 | 622 | 0.120 |
Why?
|
| Biopsy | 1 | 2020 | 6779 | 0.070 |
Why?
|
| Mortality | 1 | 2019 | 2908 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2013 | 1117 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 15912 | 0.070 |
Why?
|
| Cognition | 2 | 2013 | 7057 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 4056 | 0.060 |
Why?
|
| Humans | 16 | 2024 | 766812 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3411 | 0.050 |
Why?
|
| Disease Progression | 1 | 2019 | 13642 | 0.050 |
Why?
|
| Female | 9 | 2024 | 396532 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2023 | 551 | 0.040 |
Why?
|
| Antigens, CD1d | 1 | 2020 | 226 | 0.040 |
Why?
|
| Male | 5 | 2020 | 364154 | 0.040 |
Why?
|
| Middle Aged | 4 | 2024 | 223267 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 564 | 0.040 |
Why?
|
| Mutation | 3 | 2021 | 30214 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2021 | 1057 | 0.030 |
Why?
|
| Cicatrix | 1 | 2023 | 798 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 949 | 0.030 |
Why?
|
| Oncogenes | 1 | 2021 | 1232 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2078 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2020 | 632 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2020 | 1615 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 88902 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2024 | 2392 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 18329 | 0.030 |
Why?
|
| Aging | 1 | 2013 | 8728 | 0.030 |
Why?
|
| Synaptic Membranes | 1 | 2013 | 88 | 0.030 |
Why?
|
| Epitopes | 1 | 2020 | 2526 | 0.030 |
Why?
|
| Aged | 3 | 2024 | 171344 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 8715 | 0.020 |
Why?
|
| Child | 1 | 2020 | 80670 | 0.020 |
Why?
|
| Maze Learning | 1 | 2013 | 479 | 0.020 |
Why?
|
| Adult | 3 | 2024 | 223305 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 2952 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4277 | 0.020 |
Why?
|
| Decision Making | 1 | 2023 | 3951 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2020 | 3468 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 13411 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2020 | 3464 | 0.020 |
Why?
|
| Genome, Human | 1 | 2020 | 4443 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7612 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2021 | 18986 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8623 | 0.020 |
Why?
|
| Models, Biological | 1 | 2020 | 9464 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81657 | 0.010 |
Why?
|
| Learning | 1 | 2013 | 1754 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16722 | 0.010 |
Why?
|
| Pregnancy | 2 | 2013 | 30236 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 81898 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9546 | 0.010 |
Why?
|
| Animals | 3 | 2021 | 168939 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 24299 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15831 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2020 | 23618 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18397 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59548 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 22351 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 59939 | 0.010 |
Why?
|